ANRO
Alto Neuroscience, Inc.
NYSE · Healthcare · Biotechnology · US
$22.82
+4.01%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -1.08x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 2.91x
Liquidity & coverage
- Current ratio
- 14.85x
- Quick ratio
- 14.85x
- Cash ratio
- 14.64x
- Interest coverage
- 19.66x
- EBITDA / interest
- -35.95x
- Working capital
- $230.7M
Cash & dividend
- FCF / debt
- -9.77x
- Cash flow / debt
- -9.69x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026